单纯机械取栓术与动脉内复合方式治疗急性脑梗死的对比

被引:17
作者
姜长春
李月春
王宝军
张天佑
李霞
潘晓华
杨俊峰
机构
[1] 包头市中心医院神经内科
关键词
脑梗死; 急性; 血栓溶解疗法; 血管成形术; 机械碎栓; 机械取栓;
D O I
暂无
中图分类号
R743.3 [急性脑血管疾病(中风)];
学科分类号
1002 ;
摘要
目的比较单纯机械取栓术与动脉溶栓复合(支架置入、球囊扩张、机械碎栓)其他方式治疗急性脑梗死的疗效及安全性。方法回顾性分析包头市中心医院2004年1月—2012年1月治疗的急性脑梗死患者36例,其中17例采用动脉溶栓复合其他方式(简称复合治疗组),对19例采用单纯机械取栓术(简称机械取栓组)。采用心肌梗死溶栓分级标准(TIMI)判断血管再通情况。比较两组的疗效及安全性。以P<0.05为差异有统计学意义。结果①复合治疗组和机械取栓组血管再通患者比率分别为76.5%(13/17)、100%,P=0.025;残余狭窄率≤30%者,分别为11.8%(2/17)和47.4%(9/19),P=0.021;治疗后24 h内,美国国立卫生研究院卒中量表(NIHSS)评分两组改善者分别为17.6%(3/17)和52.6%(10/19),P=0.029。②治疗时,复合治疗组和机械取栓组栓子脱落发生率分别为5.9%(1/17)和5.3%(1/19),P=0.935;穿支血管闭塞事件发生率分别为5.9%(1/17)和0,P=0.284。治疗后24 h内,症状性颅内出血发生率分别为11.8%(2/17)和10.5%(2/19),P=0.906;两组均无患者发生治疗后急性血管再闭塞的情况;病死率分别为11.8%和10.5%,P=0.906。③治疗后3个月随访mRS≤1分者,复合治疗组和机械取栓组分别为52.9%(9/17)和89.5%(17/19),P=0.015。结论单纯机械取栓术治疗急性脑梗死与动脉溶栓复合其他方法比较,安全性接近;但由于单纯机械取栓术的血管再通率高,短期效果可能要略好于动脉溶栓联合机械方法,但需要扩大样本量进一步证实。
引用
收藏
页码:461 / 465
页数:5
相关论文
共 11 条
[1]   THROMBOLYTIC THERAPY FOR ACUTE ISCHEMIC STROKE BEYOND THREE HOURS [J].
Carpenter, Christopher R. ;
Keim, Samuel M. ;
Milne, William Kenneth ;
Meurer, William J. ;
Barsan, William G. .
JOURNAL OF EMERGENCY MEDICINE, 2011, 40 (01) :82-92
[2]   Low Rates of Acute Recanalization With Intravenous Recombinant Tissue Plasminogen Activator in Ischemic Stroke Real-World Experience and a Call for Action [J].
Bhatia, Rohit ;
Hill, Michael D. ;
Shobha, Nandavar ;
Menon, Bijoy ;
Bal, Simerpreet ;
Kochar, Puneet ;
Watson, Tim ;
Goyal, Mayank ;
Demchuk, Andrew M. .
STROKE, 2010, 41 (10) :2254-2258
[3]   Thrombolysis With 0.6 mg/kg Intravenous Alteplase for Acute Ischemic Stroke in Routine Clinical Practice The Japan post-Marketing Alteplase Registration Study (J-MARS) [J].
Nakagawara, Jyoji ;
Minematsu, Kazuo ;
Okada, Yasushi ;
Tanahashi, Norio ;
Nagahiro, Shinji ;
Mori, Etsuro ;
Shinohara, Yukito ;
Yamaguchi, Takenori .
STROKE, 2010, 41 (09) :1984-1989
[4]  
Implementation and outcome of thrombolysis with alteplase 3–4·5 h after an acute stroke: an updated analysis from SITS-ISTR.[J].Niaz Ahmed;Nils Wahlgren;Martin Grond;Michael Hennerici;Kennedy R Lees;Robert Mikulik;Mark Parsons;Risto O Roine;Danilo Toni;Peter Ringleb.Lancet Neurology.2010, 9
[5]   Analysis of the National Institute of Neurological Disorders and Stroke Tissue Plasminogen Activator Studies Following European Cooperative Acute Stroke Study III Patient Selection Criteria [J].
Hemmen, Thomas M. ;
Rapp, Karen S. ;
Emond, Jennifer A. ;
Raman, Rema ;
Lyden, Patrick D. .
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2010, 19 (04) :290-293
[6]   The impact of recanalization on ischemic stroke outcome - A meta-analysis [J].
Rha, Joung-Ho ;
Saver, Jeffrey L. .
STROKE, 2007, 38 (03) :967-973
[7]   Therapy of basilar artery occlusion - A systematic analysis comparing intra-arterial and intravenous thrombolysis [J].
Lindsberg, PJ ;
Mattle, HP .
STROKE, 2006, 37 (03) :922-928
[8]   Safety and efficacy of mechanical embolectomy in acute ischemic stroke - Results of the MERCI trial [J].
Smith, WS ;
Sung, G ;
Starkman, S ;
Saver, JL ;
Kidwell, CS ;
Gobin, YP ;
Lutsep, HL ;
Nesbit, GM ;
Grobelny, T ;
Rymer, MM ;
Silverman, IE ;
Higashida, RT ;
Budzik, RF ;
Marks, MP .
STROKE, 2005, 36 (07) :1432-1438
[9]   Biomarkers and Surrogate Markers: An FDA Perspective [J].
Katz R. .
NeuroRX, 2004, 1 (2) :189-195
[10]  
Reperfusion Therapy for Acute Middle Cerebral Artery Trunk Occlusion.[J].S. Nakano;S. Wakisaka;T. Yoneyama.Interventional Neuroradiology.2004, 1_suppl